# Medical Record Results for Member ID: 1616

## Member ID

1616

## Basic Info

```markdown
Member Information

Member ID: 1616
Age: 84
Gender: Female
```

## Diagnosis Summary

Diagnosis Summary:

Endocrine, Nutritional, and Metabolic Diseases:
- Type 2 diabetes mellitus without complications (E119) in [2017-06-28, 2017-09-25, 2017-12-18, 2018-02-02, 2018-03-01, 2018-03-05, 2018-07-26, 2018-07-28, 2018-07-29, 2018-07-30, 2018-08-02, 2018-08-09, 2018-08-20, 2018-08-22, 2018-12-11, 2019-07-16, 2019-08-12, 2019-08-15, 2019-11-18]
- Hyperlipidemia, unspecified (E785) in [2017-06-28, 2017-08-21, 2018-02-02, 2018-08-09]
- Pure hypercholesterolemia, unspecified (E7800) in [2018-07-28, 2018-07-29, 2018-07-30, 2018-08-02, 2018-08-09]

Neoplasms:
- Malignant neoplasm of bladder, unspecified (C679) in [2018-07-26, 2018-07-28, 2018-07-29, 2018-07-30, 2018-07-31, 2018-08-02, 2018-08-09, 2019-05-07]
- Malignant neoplasm of anterior wall of bladder (C673) in [2018-07-24, 2018-10-23]
- Malignant neoplasm of posterior wall of bladder (C674) in [2018-12-31]
- Neoplasm of unspecified behavior of bladder (D494) in [2018-07-26, 2019-01-29, 2019-09-03]

Diseases of the Circulatory System:
- Essential (primary) hypertension (I10) in [2017-06-28, 2018-02-02, 2018-02-12, 2018-03-01, 2018-03-05, 2018-07-28, 2018-07-29, 2018-07-30, 2018-08-02, 2018-08-09, 2018-08-22, 2018-12-11, 2019-07-16, 2019-11-18]
- Other nonrheumatic aortic valve disorders (I358) in [2018-07-25, 2018-08-16]
- Combined rheumatic disorders of mitral, aortic and tricuspid valves (I083) in [2018-08-16]

Diseases of the Genitourinary System:
- Cystocele, unspecified (N8110) in [2017-07-24, 2017-10-30, 2017-12-21, 2018-01-24, 2018-03-21, 2018-06-20, 2018-12-31]
- Urge incontinence (N3941) in [2017-12-21]
- Urinary tract infection, site not specified (N390) in [2018-02-02]
- Acute kidney failure, unspecified (N179) in [2018-02-02, 2018-02-04]

Diseases of the Eye and Adnexa:
- Age-related nuclear cataract, bilateral (H2513) in [2017-10-05]
- Age-related nuclear cataract, left eye (H2512) in [2017-10-19, 2017-10-31]
- Age-related nuclear cataract, right eye (H2511) in [2017-11-20, 2017-11-30]

Diseases of the Respiratory System:
- Influenza due to unidentified influenza virus with other respiratory manifestations (J111) in [2018-02-02, 2018-02-04, 2018-02-05, 2018-02-12, 2018-03-01, 2018-03-05]
- Cough (R05) in [2018-02-12, 2018-02-13]

Symptoms, Signs, and Abnormal Clinical and Laboratory Findings:
- Nausea with vomiting, unspecified (R112) in [2018-02-12, 2018-02-13, 2019-08-06]
- Weakness (R531) in [2018-02-12, 2018-02-13]
- Anorexia (R630) in [2018-02-12, 2018-02-13]
- Shortness of breath (R0602) in [2019-09-13]
- Dizziness and giddiness (R42) in [2019-09-13]

Infectious and Parasitic Diseases:
- Sepsis, unspecified organism (A419) in [2018-02-02]
- Infectious gastroenteritis and colitis, unspecified (A09) in [2019-08-15]

Injury, Poisoning, and Certain Other Consequences of External Causes:
- Toxic effect of other specified noxious substances eaten as food, accidental (unintentional), initial encounter (T628X1A) in [2019-08-06]
- Toxic effect of unspecified noxious substance eaten as food, accidental (unintentional), initial encounter (T6291XA) in [2019-08-06]

Other Diagnoses:
- Encounter for general adult medical examination without abnormal findings (Z0000) in [2017-06-28, 2018-08-22, 2018-12-11, 2019-11-18]
- Personal history of nicotine dependence (Z87891) in [2018-07-28, 2018-07-29, 2018-07-30, 2018-08-02, 2018-08-09, 2018-08-16]
- History of falling (Z9181) in [2018-07-28, 2018-07-29, 2018-07-30, 2018-08-02, 2018-08-09]

## Procedure Summary

Procedure Summary:

Cardiovascular Procedures:
- Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report (93000) in [2017-06-28, 2019-11-18]
- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report (93005) in [2018-02-12, 2018-02-13, 2018-07-25, 2019-09-13]
- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only (93010) in [2018-02-04]
- Rhythm ECG, 1-3 leads; tracing only without interpretation and report (93041) in [2018-02-12, 2018-02-13, 2019-09-13]
- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography (93306) in [2018-08-16]

Ophthalmological Procedures:
- Ophthalmological services: medical examination and evaluation with initiation of diagnostic and treatment program; comprehensive, new patient, 1 or more visits (92004) in [2017-10-05]
- Ophthalmic biometry by partial coherence interferometry with intraocular lens power calculation (92136) in [2017-10-19, 2017-11-20]
- Anesthesia for procedures on eye; lens surgery (00142) in [2017-10-31, 2017-11-30]
- Extracapsular cataract removal with insertion of intraocular lens prosthesis (1 stage procedure), manual or mechanical technique (eg, irrigation and aspiration or phacoemulsification); without endoscopic cyclophotocoagulation (66984) in [2017-10-31, 2017-11-30]

Urological Procedures:
- Cystourethroscopy (separate procedure) (52000) in [2018-07-24, 2018-10-23, 2019-01-29, 2019-05-07, 2019-09-03]
- Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging (51798) in [2017-12-21, 2018-12-31]
- Insertion of non-indwelling bladder catheter (eg, straight catheterization for residual urine) (51701) in [2018-02-12, 2018-02-13]

Laboratory Tests:
- Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy (81003) in [2017-07-24, 2017-10-30, 2017-12-21, 2018-01-24, 2018-03-21, 2018-06-20, 2018-07-24, 2018-10-23, 2018-12-31, 2019-01-29, 2019-05-07, 2019-08-06, 2019-09-03]
- Basic metabolic panel (Calcium, total) (80048) in [2017-08-21, 2018-02-12, 2018-02-13, 2018-07-25, 2019-08-06, 2019-09-13]
- Lipid panel (80061) in [2017-08-21, 2018-08-20]
- Hepatic function panel (80076) in [2018-02-12, 2018-02-13, 2019-08-06]
- Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count (85025) in [2018-02-12, 2018-02-13, 2019-08-06, 2019-09-13]
- Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) (85027) in [2018-07-25]
- Glucose, blood by glucose monitoring device(s) cleared by the FDA specifically for home use (82962) in [2017-09-25, 2019-11-18]
- Glucose; quantitative, blood (except reagent strip) (82947) in [2018-07-26]
- Hemoglobin; glycosylated (A1C) (83036) in [2018-08-20, 2019-08-12]
- Hemoglobin; glycosylated (A1C) by device cleared by FDA for home use (83037) in [2017-06-28]
- Transferase; aspartate amino (AST) (SGOT) (84450) in [2017-08-21, 2018-08-20, 2019-08-12]
- Transferase; alanine amino (ALT) (SGPT) (84460) in [2017-08-21, 2018-08-20, 2019-08-12]
- Troponin, quantitative (84484) in [2018-02-12, 2019-09-13]
- Lactate (lactic acid) (83605) in [2018-02-12, 2018-02-13, 2019-08-06]
- Lipase (83690) in [2018-02-12, 2018-02-13, 2019-08-06]
- Albumin; urine (eg, microalbumin), quantitative (82043) in [2018-08-20, 2019-08-12]
- Culture, bacterial; blood, aerobic, with isolation and presumptive identification of isolates (includes anaerobic culture, if appropriate) (87040) in [2018-02-12, 2018-02-13]
- Culture, bacterial; quantitative colony count, urine (87086) in [2018-02-12, 2018-02-13]
- Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative; Influenza, A or B, each (87400) in [2018-02-12, 2018-02-13]
- Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Influenza (87804) in [2018-02-02]
- Fibrin degradation products, D-dimer; quantitative (85379) in [2019-09-13]
- Prothrombin time (85610) in [2019-08-06]
- Blood, occult, by peroxidase activity (eg, guaiac), qualitative; feces, consecutive collected specimens with single determination, for colorectal neoplasm screening (ie, patient was provided 3 cards or single triple card for consecutive collection) (82270) in [2019-08-15]

Anesthesia and Pain Management:
- Anesthesia for transurethral procedures (including urethrocystoscopy); transurethral resection of bladder tumor(s) (00912) in [2018-07-26]
- Anesthesia for patient of extreme age, younger than 1 year and older than 70 (List separately in addition to code for primary anesthesia procedure) (99100) in [2017-11-30, 2018-07-26]
- Injection, ondansetron HCl, per 1 mg (J2405) in [2018-02-12, 2018-02-13, 2018-07-26, 2019-08-06]
- Injection, cefazolin sodium, 500 mg (J0690) in [2018-07-26]
- Injection, dexamethasone sodium phosphate, 1 mg (J1100) in [2018-07-26]
- Injection, propofol, 10 mg (J2704) in [2018-07-26]
- Injection, fentanyl citrate, 0.1 mg (J3010) in [2018-07-26]
- Injection, dicyclomine HCl, up to 20 mg (J0500) in [2019-08-06]
- Injection, morphine sulfate, up to 10 mg (J2270) in [2019-08-06]

Therapeutic and Diagnostic Procedures:
- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug (96374) in [2018-02-12, 2018-02-13, 2019-08-06]
- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure) (96375) in [2019-08-06]
- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular (96372) in [2019-08-06]
- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure) (96361) in [2018-02-12, 2018-02-13, 2019-08-06]
- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure) (96361) in [2018-02-12, 2018-02-13, 2019-08-06]
- Injection, intralesional; up to and including 7 lesions (11900) in [2019-08-28, 2019-10-14, 2019-12-18]

Office and Outpatient Visits:
- Office or other outpatient visit for the evaluation and management of an established patient, which requires a medically appropriate history and/or examination and low level of medical decision making. When using time for code selection, 20-29 minutes of total time is spent on the date of the encounter. (99213) in [2017-07-24, 2017-09-25, 2017-10-30, 2017-12-18, 2017-12-21, 2018-01-24, 2018-02-02, 2018-02-12, 2018-02-13, 2018-03-21, 2018-06-20, 2018-07-31, 2018-08-15, 2018-08-27, 2018-09-04, 2018-12-31, 2019-04-29]
- Office or other outpatient visit for the evaluation and management of an established patient, which requires a medically appropriate history and/or examination and moderate level of medical decision making. When using time for code selection, 30-39 minutes of total time is spent on the date of the encounter. (99214) in [2018-08-09, 2019-07-16]
- Office or other outpatient visit for the evaluation and management of a new patient, which requires a medically appropriate history and/or examination and moderate level of medical decision making. When using time for code selection, 45-59 minutes of total time is spent on the date of the encounter. (99204) in [2018-07-25]

Emergency Department Visits:
- Emergency department visit for the evaluation and management of a patient, which requires these 3 key components within the constraints imposed by the urgency of the patient's clinical condition and/or mental status: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. (99285) in [2018-02-04, 2018-02-12, 2018-02-13, 2019-08-06, 2019-09-13]
- Emergency department visit for the evaluation and management of a patient, which requires these 3 key components: A detailed history; A detailed examination; and Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. (99284) in [2018-02-12, 2019-08-06]
- Emergency department visit for the evaluation and management of a patient, which requires these 3 key components: An expanded problem focused history; An expanded problem focused examination; and Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. (99283) in [2018-07-29]
- Emergency department visit for the evaluation and management of a patient, which requires these 3 key components: An expanded problem focused history; An expanded problem focused examination; and Medical decision making of low complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. (99282) in [2018-07-29]

Hospital Care:
- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. (99223) in [2018-02-04]
- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. (99233) in [2018-02-05]

Preventive and Wellness Visits:
- Annual wellness visit, includes a personalized prevention plan of service (PPS), subsequent visit (G0439) in [2017-06-28, 2018-12-11]
- Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 65 years and older (99397) in [2018-08-22, 2019-11-18]
- Annual alcohol misuse screening, 15 minutes (G0442) in [2018-12-11]
- Annual depression screening, 15 minutes (G0444) in [2018-12-11]
- Advance care planning including the explanation and discussion of advance directives such as standard forms (with completion of such forms, when performed), by the physician or other qualified health care professional; first 30 minutes, face-to-face with the patient, family member(s), and/or surrogate (99497) in [2018-12-11]

Physical Therapy and Rehabilitation:
- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing) (97116) in [2018-02-12, 2018-02-13]
- Physical therapy evaluation: low complexity, requiring these components: A history with no personal factors and/or comorbidities that impact the plan of care; An examination of body system(s) using standardized tests and measures addressing 1-2 elements from any of the following: body structures and functions, activity limitations, and/or participation restrictions; A clinical presentation with stable and/or uncomplicated characteristics; and Clinical decision making of low complexity using standardized patient assessment instrument and/or measurable assessment of functional outcome (97161) in [2018-02-12, 2018-02-13]
- Mobility: walking and moving around functional limitation, current status, at therapy episode outset and at reporting intervals (G8978) in [2018-02-12, 2018-02-13]
- Mobility: walking and moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting (G8979) in [2018-02-12, 2018-02-13]
- Services performed by a qualified physical therapist in the home health or hospice setting, each 15 minutes (G0151) in [2018-03-01, 2018-03-05]
- Direct skilled nursing services of a registered nurse (RN) in the home health or hospice setting, each 15 minutes (G0299) in [2018-03-01, 2018-03-05, 2018-07-28, 2018-07-29, 2018-07-30, 2018-08-02, 2018-08-09]
- Direct skilled nursing services of a licensed practical nurse (LPN) in the home health or hospice setting, each 15 minutes (G0300) in [2018-08-02, 2018-08-09]

Radiological Examinations:
- Radiologic examination, chest; 2 views (71046) in [2018-02-12, 2018-02-13, 2019-09-13]
- Radiologic examination, abdomen; 2 views (74019) in [2019-08-06]
- Radiologic examination, foot; complete, minimum of 3 views (73630) in [2018-08-27]

Surgical Pathology:
- Level V - Surgical pathology, gross and microscopic examination (88307) in [2018-07-26]

Miscellaneous:
- Service(s) provided between 10:00 PM and 8:00 AM at 24-hour facility, in addition to basic service (99053) in [2018-07-29]

## Medication Summary

Prescription Medication Summary:

Cholesterol Management:
- Atorvastatin (39400010) in [2017-09-25, 2017-12-22, 2018-03-19, 2018-06-17]
- Rosuvastatin (39400060) in [2018-08-09, 2018-11-03, 2019-02-02, 2019-05-04]

Diabetes Management:
- Glucose Blood (94100030) in [2017-05-29, 2017-07-17, 2017-09-05, 2017-10-27, 2017-12-19, 2018-02-06, 2018-03-25, 2018-05-21, 2018-07-14, 2018-09-08, 2018-10-27, 2018-12-26, 2019-02-13, 2019-04-04, 2019-05-25]
- Lancets (97202025) in [2017-05-29, 2017-07-17, 2017-09-05, 2017-10-27, 2017-12-19, 2018-02-06, 2018-03-25, 2018-05-21, 2018-07-14, 2018-09-08, 2018-10-27, 2018-12-26, 2019-02-13, 2019-04-04, 2019-05-25]
- Metformin (27250050) in [2019-02-04, 2019-05-04]

Eye Care:
- Ophthalmic Anti-infective Combination - Two Ingredient (86109902) in [2017-10-10, 2017-11-10]
- Difluprednate (86300012) in [2017-10-10, 2017-11-10]
- Nepafenac (86805050) in [2017-10-10, 2017-11-13]

Antibiotics:
- Cefpodoxime (02300065) in [2018-02-07]
- Cephalexin (02100020) in [2018-07-26]
- Amoxicillin (01200010) in [2019-11-26]

Pain and Inflammation:
- Hydrocodone Combination - Two Ingredient (65991702) in [2018-07-26]
- Meloxicam (66100052) in [2018-08-09]

Blood Pressure Management:
- Losartan (36150040) in [2019-05-08]

Gastrointestinal:
- Famotidine (49200030) in [2019-11-18, 2019-12-14]

Antiviral:
- Oseltamivir (12504060) in [2018-02-02, 2018-02-07]

Antiemetic:
- Ondansetron (50250065) in [2019-08-07]

## Lab Summary

Lab Summary:

- Urea nitrogen (3094-0) in [2018-06-20:11.00] Result:UNK  
- Glomerular filtration rate/1.73 sq M.predicted.black (48643-1) in [2018-06-20:87.00] Result:UNK  
- Creatinine (2160-0) in [2018-06-20:0.74] Result:UNK

## Past Medical Conditions

1. Prioritized List of Past Medical Conditions:
   - Malignant neoplasm of bladder
   - Type 2 diabetes mellitus
   - Essential (primary) hypertension
   - Hyperlipidemia
   - Acute kidney failure
   - Age-related nuclear cataract
   - Sepsis

2. Note: See below for a summary and detailed analysis of each condition.

3. Summary of Past Health Issues:
The patient, an 84-year-old female, has a complex medical history with significant conditions impacting her current health status. The most critical condition is the malignant neoplasm of the bladder, diagnosed multiple times between 2018 and 2019, which required several cystourethroscopies. Type 2 diabetes mellitus, managed since 2017, poses ongoing challenges, particularly in conjunction with essential hypertension and hyperlipidemia, both of which increase cardiovascular risk. Acute kidney failure episodes in 2018 highlight renal vulnerability, potentially exacerbated by diabetes and hypertension. Age-related nuclear cataracts were addressed surgically in 2017, improving visual function. A sepsis episode in 2018 underscores the patient's susceptibility to severe infections. These conditions collectively influence her current health, necessitating comprehensive management strategies.

4. Detailed Analysis of Each Past Medical Condition:

   - Malignant Neoplasm of Bladder:
     - Diagnosed: 2018-07-26 (C679), 2018-07-24 (C673), 2018-12-31 (C674)
     - Procedures: Cystourethroscopy (52000) on 2018-07-24, 2018-10-23, 2019-01-29
     - Lab Tests: Urinalysis (81003) on 2018-07-24, 2018-10-23
     - Impact: Requires ongoing monitoring and treatment, potential for recurrence.

   - Type 2 Diabetes Mellitus:
     - Diagnosed: 2017-06-28 (E119)
     - Medications: Metformin (27250050) from 2019-02-04
     - Lab Tests: Hemoglobin A1C (83036) on 2018-08-20, 2019-08-12
     - Impact: Chronic management required to prevent complications.

   - Essential (Primary) Hypertension:
     - Diagnosed: 2017-06-28 (I10)
     - Medications: Losartan (36150040) from 2019-05-08
     - Lab Tests: Basic metabolic panel (80048) on 2018-02-12
     - Impact: Increases risk for cardiovascular and renal complications.

   - Hyperlipidemia:
     - Diagnosed: 2017-06-28 (E785)
     - Medications: Atorvastatin (39400010) from 2017-09-25
     - Lab Tests: Lipid panel (80061) on 2017-08-21
     - Impact: Contributes to cardiovascular risk, requires lipid management.

   - Acute Kidney Failure:
     - Diagnosed: 2018-02-02 (N179)
     - Lab Tests: Creatinine (2160-0) on 2018-06-20
     - Impact: Indicates renal vulnerability, necessitates careful monitoring.

   - Age-related Nuclear Cataract:
     - Diagnosed: 2017-10-05 (H2513)
     - Procedures: Cataract removal (66984) on 2017-10-31
     - Impact: Improved vision post-surgery, requires regular eye exams.

   - Sepsis:
     - Diagnosed: 2018-02-02 (A419)
     - Lab Tests: Blood culture (87040) on 2018-02-12
     - Impact: Highlights infection risk, requires vigilance for future infections.

This detailed analysis provides a comprehensive view of the patient's past medical conditions, their management, and their impact on current health status.

## Potential Future Conditions

1. Prioritized List of Potential Future Conditions:
   - Cardiovascular Disease
   - Chronic Kidney Disease
   - Recurrent Bladder Cancer
   - Diabetic Complications (e.g., neuropathy, retinopathy)
   - Osteoporosis

2. Note: See below for a summary and detailed analysis of each condition.

3. Summary of Potential Future Health Risks:
The patient, an 84-year-old female, presents with a history of type 2 diabetes, hypertension, hyperlipidemia, and previous bladder cancer, all of which contribute to her risk profile for future health issues. Cardiovascular disease is a significant concern due to the combination of diabetes, hypertension, and hyperlipidemia, which are known risk factors. Chronic kidney disease is another potential risk, given her history of acute kidney failure and diabetes. The recurrence of bladder cancer remains a possibility, necessitating vigilant monitoring. Diabetic complications such as neuropathy and retinopathy are potential future concerns due to the chronic nature of diabetes. Additionally, osteoporosis is a risk due to her age and potential history of falls. Preventive measures, including regular monitoring, lifestyle modifications, and adherence to treatment plans, are crucial to mitigate these risks.

4. Detailed Analysis of Each Potential Future Condition:

   - Cardiovascular Disease:
     - Risk Factors: Type 2 diabetes, hypertension, hyperlipidemia.
     - Evidence: Essential hypertension (I10) diagnosed on 2017-06-28, hyperlipidemia (E785) diagnosed on 2017-06-28, type 2 diabetes (E119) diagnosed on 2017-06-28.
     - Medications: Losartan for hypertension, atorvastatin for hyperlipidemia.
     - Lab Tests: Lipid panel (80061) on 2017-08-21; normal ranges: Total cholesterol <200 mg/dL, LDL <100 mg/dL, HDL >40 mg/dL, triglycerides <150 mg/dL.
     - Likelihood: High, given the combination of risk factors.
     - Preventive Measures: Regular cardiovascular assessments, lifestyle changes (diet, exercise), medication adherence.

   - Chronic Kidney Disease:
     - Risk Factors: History of acute kidney failure, diabetes.
     - Evidence: Acute kidney failure (N179) diagnosed on 2018-02-02.
     - Lab Tests: Creatinine (2160-0) on 2018-06-20; normal range: 0.6-1.2 mg/dL.
     - Likelihood: Moderate to high, due to diabetes and past kidney issues.
     - Preventive Measures: Regular kidney function tests, blood pressure control, diabetes management.

   - Recurrent Bladder Cancer:
     - Risk Factors: Previous bladder cancer diagnoses.
     - Evidence: Malignant neoplasm of bladder (C679) diagnosed on 2018-07-26.
     - Procedures: Cystourethroscopy (52000) on 2018-07-24.
     - Likelihood: Moderate, based on past occurrences.
     - Preventive Measures: Regular urological evaluations, monitoring for symptoms.

   - Diabetic Complications:
     - Risk Factors: Long-standing diabetes.
     - Evidence: Type 2 diabetes (E119) diagnosed on 2017-06-28.
     - Lab Tests: Hemoglobin A1C (83036) on 2018-08-20; normal range: <5.7%.
     - Likelihood: High, given the chronic nature of diabetes.
     - Preventive Measures: Tight glycemic control, regular screenings for complications.

   - Osteoporosis:
     - Risk Factors: Advanced age, history of falls.
     - Evidence: History of falling (Z9181) noted on 2018-07-28.
     - Likelihood: Moderate to high, due to age and fall history.
     - Preventive Measures: Bone density testing, calcium and vitamin D supplementation, fall prevention strategies. 

This comprehensive analysis outlines the potential future health risks for the patient, emphasizing the importance of proactive management and preventive care to maintain her health and quality of life.

## Common Q&A

### Important Questions to Discuss with Your Doctor

#### Question 1:
How can I effectively manage my type 2 diabetes alongside my other health conditions, such as hypertension and hyperlipidemia?

**Suggested Answer:**
Managing type 2 diabetes effectively involves a combination of lifestyle changes, medication adherence, and regular monitoring. It's important to maintain a balanced diet, engage in regular physical activity, and monitor your blood sugar levels as advised by your healthcare provider. Since you also have hypertension and hyperlipidemia, your doctor may recommend medications like Metformin for diabetes, Losartan for blood pressure, and Atorvastatin for cholesterol management. Regular check-ups and lab tests, such as Hemoglobin A1C and lipid panels, are crucial to assess your progress and adjust treatments as needed.

**Why This Matters:**
Effective management of diabetes is critical to prevent complications such as cardiovascular disease and kidney damage, especially when other conditions like hypertension and hyperlipidemia are present. Coordinating care for these conditions can help reduce the risk of serious health issues.

#### Question 2:
What are the best strategies to monitor and prevent the recurrence of bladder cancer?

**Suggested Answer:**
Preventing the recurrence of bladder cancer involves regular follow-up appointments with your urologist, who may recommend periodic cystourethroscopies to monitor the bladder. It's also important to report any new symptoms, such as blood in the urine or changes in urination patterns, to your doctor immediately. Lifestyle changes, such as quitting smoking and maintaining a healthy diet, can also help reduce the risk of recurrence.

**Why This Matters:**
Bladder cancer has a risk of recurrence, and early detection of any changes can lead to more effective treatment. Regular monitoring and lifestyle modifications are key components in managing this risk.

#### Question 3:
Given my history of acute kidney failure, what steps should I take to protect my kidney health?

**Suggested Answer:**
To protect your kidney health, it's important to manage your blood pressure and blood sugar levels effectively, as both hypertension and diabetes can impact kidney function. Regular kidney function tests, such as creatinine and glomerular filtration rate (GFR), can help monitor your kidney health. Staying hydrated, avoiding non-prescribed medications that can harm the kidneys, and following a kidney-friendly diet as recommended by your healthcare provider are also important steps.

**Why This Matters:**
Your history of acute kidney failure indicates a vulnerability in kidney function. Proactive management and regular monitoring can help prevent further kidney damage and maintain overall health.

## Evaluation Results

Evaluation Report:

Diagnosis Discrepancies:

- The generated summary includes "Type 2 diabetes mellitus without complications (E119)" on 2019-08-15, which is not present in the original data for that date.
- The generated summary includes "Influenza due to unidentified influenza virus with other respiratory manifestations (J111)" on 2018-02-05, which is not present in the original data for that date.

Procedure Discrepancies:

- No discrepancies found. All generated summaries accurately match the original patient data.

Medication Discrepancies:

- No discrepancies found. All generated summaries accurately match the original patient data.

Lab Test Discrepancies:

- No discrepancies found. All generated summaries accurately match the original patient data.

Past Medical Condition Discrepancies:

- No discrepancies found. All generated summaries accurately match the original patient data.

Future Medical Condition Discrepancies:

- No discrepancies found. All generated summaries accurately match the original patient data.

